XR Securities LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 190 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
XR Securities LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$36,000
+12.5%
12,200
-64.8%
0.00%
-50.0%
Q2 2020$32,000
+113.3%
34,700
+191.6%
0.00%
+300.0%
Q1 2020$15,000
+1400.0%
11,900
+15.5%
0.00%
Q4 2019$1,000
-75.0%
10,300
-9.6%
0.00%
-100.0%
Q3 2019$4,000
-66.7%
11,400
-2.6%
0.00%
-50.0%
Q2 2019$12,000
-29.4%
11,700
+17.0%
0.00%
-71.4%
Q4 2018$17,000
-70.7%
10,000
-35.9%
0.01%
-53.3%
Q3 2018$58,00015,6000.02%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders